India's most comprehensive portal on pharmaceutical News, …
3 days ago · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Schedule H list revised with a total of 517 drugs under prescription ...
The union ministry of health is expected to come out with a revised Schedule H list bringing 517 drugs under the prescription category. Drugs like Nimesulide, Letrozole, Celecoxib, anti-retrovirals etc have all found place in the new list. There are about 300 new drugs that would find way into the revised Schedule H.
Health ministry bans 156 FDCs with immediate effect
Gireesh Babu, New Delhi Thursday, August 22, 2024, 13:30 Hrs [IST] The Union ministry of health and family welfare (MoHFW) has banned 156 fixed dose combinations including common cold, fever, antibacterial and antifungal medicines with immediate effect, stating that they are irrational combinations and use of these drugs is likely to involve ...
Cinven acquires UK-based Mercury Pharma for £465 million from …
London | Saturday, August 18, 2012, 09:00 Hrs [IST] Cinven, an European private equity firm, has reached agreement to acquire UK-based specialty pharmaceutical company, Mercury Pharma (Mercury), as a platform for further industry consolidation. The company has been acquired from HgCapital for an enterprise value of £465 million.
Lupin receives US FDA approval for prednisolone acetate …
Aug 5, 2024 · Our Bureau, Mumbai Monday, August 5, 2024, 15:50 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for prednisolone acetate ophthalmic suspension USP, 1% to market a generic equivalent of Pred Forte ...
CDSCO launched series of digital initiatives to streamline ...
Aug 30, 2024 · Shardul Nautiyal, Greater Noida Friday, August 30, 2024, 08:00 Hrs [IST] The Central Drugs Standard Control Organization (CDSCO) has launched a series of digital initiatives aimed at revolutionizing the pharmaceutical regulatory framework in India. These initiatives, showcased at the iPHEX 2024 event, are designed to enhance transparency ...
DCA Telangana raids & seizes illegally made cough syrups in …
Sep 14, 2024 · DCA Telangana raids & seizes illegally made cough syrups in Hyderabad. The Central government notified the revised Schedule M and the DCGI made the standards of the drug manufacturing companies stricter because of a scandal that the Indian made cough syrups were the reason for the deaths of 66 children in the Gambia in 2022, but still cough ...
Lupin receives US FDA tentative approval for generic Xarelto tablets
Wednesday, January 24, 2024, 11:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg, to market a generic equivalent of Xarelto ...
CDSCO announces five more forms going live in NSWS portal
Jan 18, 2024 · CDSCO announces five more forms going live in NSWS portal: Gireesh Babu, New Delhi Thursday, January 18, 2024, 08:00 Hrs [IST] After rolling out the single window system for the pharma and medical devices industry in the beginning of January, the Central Drugs Standard Control Organisation (CDSCO) has expanded the activities it offers through the portal to forms for permission to manufacture ...
Printed version of IP 2022 to remain official amid digital launch ...
Sep 16, 2024 · Printed version of IP 2022 to remain official amid digital launch, clarifies Dr Rajeev Singh Raghuvanshi: Shardul Nautiyal, Mumbai Monday, September 16, 2024, 08:00 Hrs [IST]